Global access to antifungal therapy and its variable cost

Cryptococcal Meningitis Treatment Strategies Affected by the Explosive Cost of Flucytosine in the United States: A Cost-effectiveness Analysis

(2016) Matthew Merry et al.   CLINICAL INFECTIOUS DISEASES

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

(2016) Thomas F. Patterson et al.   CLINICAL INFECTIOUS DISEASES

Antifungal Agents

(2016) Jeniel E. Nett et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

The Global Burden of Fungal Diseases

(2016) Snigdha Vallabhaneni et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

(2015) Peter G. Pappas et al.   CLINICAL INFECTIOUS DISEASES

Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management

(2015) David W. Denning et al.   EUROPEAN RESPIRATORY JOURNAL

Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis). Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013)

(2015) W. Mendling et al.   GEBURTSHILFE UND FRAUENHEILKUNDE

Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review

(2014) A. S. Moreira et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Itraconazole vs. trimethoprim–sulfamethoxazole: A comparative cohort study of 200 patients with paracoccidioidomycosis

(2014) Sheila Rocha Conceição Borges et al.   MEDICAL MYCOLOGY

Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria

(2013) R. Agarwal et al.   CLINICAL AND EXPERIMENTAL ALLERGY

ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients

(2013) E. Tacconelli et al.   CLINICAL MICROBIOLOGY AND INFECTION

Amphotericin B Formulations: A Comparative Review of Efficacy and Toxicity

(2013) Richard J. Hamill   DRUGS

Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries

(2013) Angela Loyse et al.   LANCET INFECTIOUS DISEASES

Combination Antifungal Therapy for Cryptococcal Meningitis

(2013) Jeremy N. Day et al.   NEW ENGLAND JOURNAL OF MEDICINE

A phase II randomized controlled trial adding oral flucytosine to high-dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis

(2012) Arthur T. Jackson et al.   AIDS

Clinical Practice Guidelines for the Management of Blastomycosis: 2008 Update by the Infectious Diseases Society of America

(2008) Stanley W. Chapman et al.   CLINICAL INFECTIOUS DISEASES